Related references
Note: Only part of the references are listed.Prevalence and clinical-demographic correlates of hyperhomocysteinemia in inpatients with bipolar disorder in a Han Chinese population
Shuang-Jiang Zhou et al.
PSYCHIATRY RESEARCH (2018)
A Comprehensive Review on the Efficacy of S-Adenosyl-L-Methionine in Major Depressive Disorder
Domenico De Berardis et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2016)
S-Adenosyl Methionine in the Therapy of Depression and Other Psychiatric Disorders
Natasa Karas Kuzelicki
DRUG DEVELOPMENT RESEARCH (2016)
Major depressive disorder
Christian Otte et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Erythrocyte fatty acid profiles and plasma homocysteine, folate and vitamin B6 and B12 in recurrent depression: Implications for co-morbidity with cardiovascular disease
Johanna Assies et al.
PSYCHIATRY RESEARCH (2015)
6 The association between alexithymia as assessed by the 20-item Toronto Alexithymia Scale and depression: A meta-analysis
Shuwen Li et al.
PSYCHIATRY RESEARCH (2015)
Plasma homocysteine levels in depression and schizophrenia in South Indian Tamilian population
Sunil K. Narayan et al.
INDIAN JOURNAL OF PSYCHIATRY (2014)
Homocysteine, depression and cognitive function in older adults
Andrew H. Ford et al.
JOURNAL OF AFFECTIVE DISORDERS (2013)
The neuropsychiatry of inborn errors of metabolism
Mark Walterfang et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2013)
Hyperhomocysteinemia in Bipolar Depression: Clinical and Biochemical Correlates
Agnieszka Permoda-Osip et al.
NEUROPSYCHOBIOLOGY (2013)
Oxidative stress and inflammatory markers are associated with depression and nicotine dependence
Heber Odebrecht Vargas et al.
NEUROSCIENCE LETTERS (2013)
Alexithymia and low cooperativeness are associated with suicide attempts in male military personnel with adjustment disorder: A case-control study
Kyoung-Sae Na et al.
PSYCHIATRY RESEARCH (2013)
S-Adenosyl-L-Methionine Augmentation in Patients with Stage II Treatment-Resistant Major Depressive Disorder: An Open Label, Fixed Dose, Single-Blind Study
Domenico De Berardis et al.
SCIENTIFIC WORLD JOURNAL (2013)
Hyperhomocysteinemia in health and disease: where we are now, and where do we go from here?
Giuseppe Lippi et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2012)
Hyperhomocysteinemia increases permeability of the blood-brain barrier by NMDA receptor-dependent regulation of adherens and tight junctions
Richard S. Beard et al.
BLOOD (2011)
Hyperhomocysteinemia and schizophrenia: Case control study
H. Mabrouk et al.
ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE (2011)
Is alexithymia a risk factor for major depression, personality disorder, or alcohol use disorders? A prospective population-based study
Kirsi Honkalampi et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2010)
Relative Hyperhomocysteinemia in Patients with Panic Disorder: A Case-Control Study
Christian Meier et al.
NEUROPSYCHOBIOLOGY (2010)
The role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric diseases
Rima Obeid et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2007)
Review of the role of Hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric disorders - Current evidence and preliminary recommendations
W. Herrmann et al.
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE (2007)
Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis
JW Muntjewerff et al.
MOLECULAR PSYCHIATRY (2006)
Elevated levels of homocysteine compromise blood-brain barrier integrity in mice
AF Kamath et al.
BLOOD (2006)
An evaluation of the absolute and relative stability of alexithymia in patients with major depression
O Luminet et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2001)
Share Paper
